Phagocyte Activation by Trp-Lys-Tyr-Met-Val-Met, Acting through FPRL1/LXA4R, is not Affected by Lipoxin A4-Reference-Cited by-同舟云学术

Phagocyte Activation by Trp-Lys-Tyr-Met-Val-Met, Acting through FPRL1/LXA4R, is not Affected by Lipoxin A4

Published:2002-10-31 Issue:5 Volume:56 Page:470-476
ISSN:0300-9475
Container-title:Scandinavian Journal of Immunology
language:en
Short-container-title:

Author:

Christophe T.,Karlsson A.,Rabiet M.-J.,Boulay F.,Dahlgren C.

Publisher

Wiley

Subject

Immunology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-3083.2002.01149.x/fullpdf

Reference31 articles.

1. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains;Gao;J Biol Chem,1993

2. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family;Murphy;J Biol Chem,1992

3. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor;Ye;Biochem Biophys Res Commun,1992

4. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor;Fiore;J Exp Med,1994

5. T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors;Su;J Immunol,1999

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A signaling network map of Lipoxin (LXA4): an anti-inflammatory molecule;Inflammation Research;2024-04-26

2. Resolution pharmacology and the treatment of infectious diseases;British Journal of Pharmacology;2024-02-14

3. Mechanisms of ERK phosphorylation triggered via mouse formyl peptide receptor 2;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2022-12

4. Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?;Frontiers in Pharmacology;2022-03-02

5. Multipathway In Vitro Pharmacological Characterization of Specialized Proresolving G Protein-Coupled Receptors;Molecular Pharmacology;2022-02-06